ReproCELL Incorporated (TYO:4978)

Japan flag Japan · Delayed Price · Currency is JPY
171.00
-1.00 (-0.58%)
Jun 26, 2025, 3:25 PM JST
24.82%
Market Cap 16.29B
Revenue (ttm) 2.98B
Net Income (ttm) 103.00M
Shares Out 94.69M
EPS (ttm) 1.11
PE Ratio 155.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 603,300
Average Volume 1,701,530
Open 172.00
Previous Close 172.00
Day's Range 169.00 - 173.00
52-Week Range 97.00 - 277.00
Beta 0.77
RSI 48.03
Earnings Date Aug 8, 2025

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 96
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4978
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.